These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 20371768)

  • 21. Comprehensive screening of a North American Parkinson's disease cohort for LRRK2 mutation.
    Johnson J; Paisán-Ruíz C; Lopez G; Crews C; Britton A; Malkani R; Evans EW; McInerney-Leo A; Jain S; Nussbaum RL; Foote KD; Mandel RJ; Crawley A; Reimsnider S; Fernandez HH; Okun MS; Gwinn-Hardy K; Singleton AB
    Neurodegener Dis; 2007; 4(5):386-91. PubMed ID: 17622782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of 14 LRRK2 mutations in Parkinson's plus syndromes and late-onset Parkinson's disease.
    Tan EK; Skipper L; Chua E; Wong MC; Pavanni R; Bonnard C; Kolatkar P; Liu JJ
    Mov Disord; 2006 Jul; 21(7):997-1001. PubMed ID: 16602113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Zeroing in on LRRK2-linked pathogenic mechanisms in Parkinson's disease.
    Biskup S; West AB
    Biochim Biophys Acta; 2009 Jul; 1792(7):625-33. PubMed ID: 18973807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Molecular basis of Parkinson's disease linked with mutations in the LRRK2 gene].
    Pchelina SN; emel'ianov AK; Usenko TS
    Mol Biol (Mosk); 2014; 48(1):3-14. PubMed ID: 25842821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LRRK2 GTPase dysfunction in the pathogenesis of Parkinson's disease.
    Xiong Y; Dawson VL; Dawson TM
    Biochem Soc Trans; 2012 Oct; 40(5):1074-9. PubMed ID: 22988868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of reactive oxygen species and genetic mitochondrial mutations in Parkinson's disease.
    Zuo L; Motherwell MS
    Gene; 2013 Dec; 532(1):18-23. PubMed ID: 23954870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel LRRK2 mutation in an Austrian cohort of patients with Parkinson's disease.
    Haubenberger D; Bonelli S; Hotzy C; Leitner P; Lichtner P; Samal D; Katzenschlager R; Djamshidian A; Brücke T; Steffelbauer M; Bancher C; Grossmann J; Ransmayr G; Strom TM; Meitinger T; Gasser T; Auff E; Zimprich A
    Mov Disord; 2007 Aug; 22(11):1640-3. PubMed ID: 17523199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. On the road to leucine-rich repeat kinase 2 signalling: evidence from cellular and in vivo studies.
    Daniëls V; Baekelandt V; Taymans JM
    Neurosignals; 2011; 19(1):1-15. PubMed ID: 21430363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Presynaptic dysfunction in Parkinson's disease: a focus on LRRK2.
    Belluzzi E; Greggio E; Piccoli G
    Biochem Soc Trans; 2012 Oct; 40(5):1111-6. PubMed ID: 22988874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alterations in late endocytic trafficking related to the pathobiology of LRRK2-linked Parkinson's disease.
    Rivero-Ríos P; Gómez-Suaga P; Fernández B; Madero-Pérez J; Schwab AJ; Ebert AD; Hilfiker S
    Biochem Soc Trans; 2015 Jun; 43(3):390-5. PubMed ID: 26009181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leucine-rich repeat kinase 2 modulates cyclooxygenase 2 and the inflammatory response in idiopathic and genetic Parkinson's disease.
    Lopez de Maturana R; Aguila JC; Sousa A; Vazquez N; Del Rio P; Aiastui A; Gorostidi A; Lopez de Munain A; Sanchez-Pernaute R
    Neurobiol Aging; 2014 May; 35(5):1116-24. PubMed ID: 24360742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigating convergent actions of genes linked to familial Parkinson's disease.
    Wolozin B; Saha S; Guillily M; Ferree A; Riley M
    Neurodegener Dis; 2008; 5(3-4):182-5. PubMed ID: 18322385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. α-Synuclein, leucine-rich repeat kinase-2, and manganese in the pathogenesis of Parkinson disease.
    Covy JP; Giasson BI
    Neurotoxicology; 2011 Oct; 32(5):622-9. PubMed ID: 21238487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LRRK2 delays degradative receptor trafficking by impeding late endosomal budding through decreasing Rab7 activity.
    Gómez-Suaga P; Rivero-Ríos P; Fdez E; Blanca Ramírez M; Ferrer I; Aiastui A; López De Munain A; Hilfiker S
    Hum Mol Genet; 2014 Dec; 23(25):6779-96. PubMed ID: 25080504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LRRK2 R1441G in Spanish patients with Parkinson's disease.
    Mata IF; Taylor JP; Kachergus J; Hulihan M; Huerta C; Lahoz C; Blazquez M; Guisasola LM; Salvador C; Ribacoba R; Martinez C; Farrer M; Alvarez V
    Neurosci Lett; 2005 Jul; 382(3):309-11. PubMed ID: 15925109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phosphorylation of LRRK2: from kinase to substrate.
    Lobbestael E; Baekelandt V; Taymans JM
    Biochem Soc Trans; 2012 Oct; 40(5):1102-10. PubMed ID: 22988873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The mouse/human cross-species heterodimer of leucine-rich repeat kinase 2: possible significance in the transgenic model mouse of Parkinson's disease.
    Miyajima T; Ohta E; Kawada H; Maekawa T; Obata F
    Neurosci Lett; 2015 Feb; 588():142-6. PubMed ID: 25562633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroprotective Effect of the LRRK2 Kinase Inhibitor PF-06447475 in Human Nerve-Like Differentiated Cells Exposed to Oxidative Stress Stimuli: Implications for Parkinson's Disease.
    Mendivil-Perez M; Velez-Pardo C; Jimenez-Del-Rio M
    Neurochem Res; 2016 Oct; 41(10):2675-2692. PubMed ID: 27394417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A common leucine-rich repeat kinase 2 gene mutation in familial and sporadic Parkinson's disease in Russia.
    Illarioshkin SN; Shadrina MI; Slominsky PA; Bespalova EV; Zagorovskaya TB; Bagyeva GKh; Markova ED; Limborska SA; Ivanova-Smolenskaya IA
    Eur J Neurol; 2007 Apr; 14(4):413-7. PubMed ID: 17388990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LRRK2 Parkinson's disease: from animal models to cellular mechanisms.
    Lin CH; Tsai PI; Wu RM; Chien CT
    Rev Neurosci; 2011; 22(4):411-8. PubMed ID: 21679126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.